Physician profile
Robert A Stringer
NPI 1225235310
$296.37
in general payments reported to CMS, 2019-2025
11 companies · $44.85 in 2025
The $44.85 reported for 2025 was less than what a typical Surgery provider received nationally (typical 2025 total: $281).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $75.05 · 2020: $12.46 · 2021: $41.85 · 2022: $39.24 · 2023: $17.58 · 2024: $65.34 · 2025: $44.85.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $128.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $127.77 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Depuy Synthes Sales INC. | $62.16 | 2019 | |
| Kerecis Limited | $41.52 | 2024-2025 | Kerecis Surgiclose, Kerecis Omega3 Marigen, Kerecis Graftguide |
| Medela LLC | $41.50 | 2021-2022 | |
| Smith+Nephew, INC. | $23.91 | 2024 | Pico 7 |
| Lilly USA, LLC | $23.85 | 2025 | Zepbound, Mounjaro |
| Ethicon US, LLC | $22.12 | 2021 | |
| Atricure, INC. | $20.91 | 2024 | |
| Access Pro Medical, LLC | $17.58 | 2023 | Matriderm |
| Medtronic, INC. | $17.47 | 2022 | |
| Mallinckrodt Enterprises LLC | $12.89 | 2019 | |
| Kls-Martin L.P. | $12.46 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Robert Stringer listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.